Objectives: To evaluate implant survival, peri-implant marginal bone loss, technical, and biological complications as well as aesthetic outcomes of zirconia implants in clinical studies. investigating zirconia dental implants with a mean follow-up of at least 12 months.
more natural, tooth-like colored implant material. Thus, at the end of the 1960s, the first ceramic dental implants made from alumina were developed (Sandhaus, 1968) , scientifically investigated and clinically used for a few decades until the early 1990s (De Wijs, Van Dongen, De Lange, & De Putter, 1994; Schlegel, Jacobs, & Leitenstorfer, 1994; Zetterqvist, Anneroth, & Nordenram, 1991) . However, due to their poor biomechanical properties -alumina implants were prone to fracture when loaded extra-axially (Andreiotelli, Wenz, & Kohal, 2009 ) -these ceramic implants were finally removed from the market. At the beginning of the 1990s, a new material called "zirconium dioxide" (zirconia, ZrO 2 ) was introduced to dentistry. In comparison with other ceramics, zirconia shows superior biomechanical properties such as a high fracture toughness and bending strength (Christel, Meunier, Heller, Torre, & Peille, 1989) giving these implants the ability to withstand oral occlusal forces ).
Thus, zirconia is currently the material of choice for the fabrication of ceramic dental implants. As implant material, several advantages, such as its color, significantly reduced in vitro bacterial biofilm formation, and reduced numbers of inflammatory cells in the peri-implant soft tissues of healing caps and abutments have been reported for zirconia compared with titanium (Degidi et al., 2006; Roehling et al., 2017; Welander, Abrahamsson, & Berglundh, 2008) . Equivalent to titanium, experimental studies have shown that increased surface roughness of zirconia implants is correlated with a higher degree of bone-to-implant contact and that micro-rough zirconia implants (Sa range 0.6-0.7 μm) show a comparable osseointegrative capacity to micro-rough titanium implants (Sa = 1.3 μm, Gahlert et al., 2007; Gahlert, Roehling, et al., 2012; Janner et al., 2018) .
At the beginning of 2004, the first 1-piece zirconia dental implants were established on the market. Initially, creating micro-rough surface topographies without compromising the biomechanical stability of zirconia implants was a technical challenge.
Thus, reduced survival rates and numerous zirconia implant fractures were reported for the first generation of zirconia implants (Gahlert, Burtscher, Grunert, Kniha, & Steinhauser, 2012; Gahlert et al., 2013; Osman, Swain, Atieh, Ma, & Duncan, 2014; Roehling, Woelfler, Hicklin, Kniha, & Gahlert, 2016) . Since then, the industry has constantly improved manufacturing processes to gain microroughened zirconia implants with reliable fracture rates and fatigue strength. In addition, zirconia implants were developed not only in terms of the surface microstructure but also with regard to their macroscopic design. In contrast, the first zirconia implant systems were limited to a 1-piece design, and 2-piece zirconia implants with a cement-or screw-retained abutment and supra structures have also become available. Consequently, within the last 14 years, different zirconia implant generations with varying designs, diameters, physical properties and surface topography characteristics were introduced on the market. On the one hand, these developments have made zirconia implants a reliable treatment option with survival rates of more than 96% for an investigation period of 5 years (Grassi et al., 2015) . On the other hand, the different implant generations can be confusing for the interpretation of published scientific data and for the clinical application of zirconia implants, which becomes even more relevant as most recently published systematic reviews and meta-analyses have pooled the available data on zirconia implants without considering the different physical properties and ongoing market availability of the investigated zirconia implants (Hashim, Cionca, Courvoisier, & Mombelli, 2016; Pieralli, Kohal, Jung, Vach, & Spies, 2017) . Thus, the clinical relevance of the outcomes reported in the latter studies is rather controversial as only 5.3% (Hashim et al., 2016) and 55.3% (Pieralli et al., 2017) of the investigated implants were available on the market.
The objective of the present systematic review was to collect clinical data on zirconia implants with regard to survival rates, marginal bone loss, technical and biological complications as well as aesthetic outcomes. Moreover, the ongoing market availability of the investigated zirconia implants was considered for the first time to identify if significant changes regarding clinical outcomes have occurred over time.
| MATERIAL S AND ME THODS
This systematic review was conducted according to the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P (Moher et al., 2015) ) statement using the Population, Intervention, Comparison and Outcome (PICO) method (Schardt, Adams, Owens, Keitz, & Fontelo, 2007) . The protocol for this systematic review was registered on PROSPERO (CRD42016049624).
| Focused question
For the present review, the focused (PICO) question to be addressed was as follows: "In clinical studies, what are the outcomes of zirconia dental implants with regard to implant survival, peri-implant marginal bone loss, technical and biological complications as well as aesthetic outcomes?"
| Search strategy
An electronic, systematic search of the Medline via Pubmed and Embase via Elsevier databases was performed in March 2017.
Articles in the English and German languages were included. For the literature search, clinical as well as preclinical studies were included.
However, the present review includes only data from clinical studies. For the Medline search, the following terms and combinations were applied: "Dental implants" [MeSH] OR "dental implantation" [MeSH] AND "zirconium oxide" [MeSH] OR "yttria-stabilized tetragonal zirconia"
[MeSH] OR "zirconia" OR "zirconia implant*" OR "ceramic implant*" AND "osseointegration" [MeSH] or "bone-implant-interface" [MeSH] or "survival rate" [MeSH] or "success rate" or "marginal bone loss" or "soft tissue".
With regard to the Embase search, the following EMTREE words and combination were used: "tooth implant" OR "tooth implantation" AND "zirconium oxide".
In addition to the electronic search, a hand search of the reference list of all included full-texts was performed.
For the electronic Medline search, reference management software (Endnote X 7.7.1, Thomson Reuters) was used. The obtained publications from the Embase search were also imported into the reference management software and finally screened.
| Inclusion criteria
For the systematic review, the following inclusion criteria were defined:
• Human trials investigating zirconia implants published between January 2000 and March 2017
• Studies at all levels of evidence, except expert opinion 
| Exclusion criteria
Studies not meeting the inclusion criteria were excluded from the review. Moreover, clinical studies investigating individually designed zirconia implants or multiple publications on the same patient population, as well as investigations based on charts, questionnaires or interviews, were excluded.
| Selection of studies
After elimination of duplicates, the reviewers (SR, MG) independently screened titles, abstracts and full-texts meeting the selection criteria. Unclear titles were included in the abstract screening. If titles or abstracts did not provide sufficient information for selection, full texts were obtained. Any disagreement with regard to inclusion and exclusion was resolved by discussion between the reviewers. To evaluate the agreement between the reviewers, Cohen′s kappa coefficient (κ) was calculated for title and abstract selection (Landis & Koch, 1977) .
| Data extraction and outcome measures
Data extraction by the reviewers was independently performed for all included studies (SR, MG) using data extraction tables.
Disagreement with regard to data extraction was resolved by discussion. In case of missing or unclear information, the corresponding authors of the papers were contacted via email. If the information was still not sufficient for inclusion and evaluation, the study was excluded for the present review.
The timing of implant placement was classified as defined by Hammerle, Chen and Wilson (2004) :
• Type 1: Immediate implant placement following tooth extraction.
• Type 2: Early implant placement after complete soft tissue healing The biological complications included bone loss of more than 2 mm over the observation periods, soft tissue complications (swelling, fistulas, mucositis) and peri-implantitis.
Aesthetic outcomes were evaluated using the pink aesthetic score (PES) according to Furhauser et al. (2005) or the papilla index according to Jemt (1997) .
For all included clinical studies, the ongoing market clinical availability of the investigated zirconia implants was considered.
Prototype zirconia implants that have never been commercially available or zirconia implant types or surface topographies that have been removed from the market while being further developed are defined in the text as "Not Commercially Available (NCA)" implants.
Zirconia implant types and surface topographies that are still commercially available as investigated in the included studies are defined as "Commercially Available (CA)" implants. 
| Statistical analysis
For survival rates as well as for MBL after an observation period of 1 year, a random-effect meta-analysis was performed. The number of implants as well as standard errors, confidence intervals and weights depending on the final number of implants was included in the statistical analysis with regard to the estimation of survival rates. The amount of heterogeneity across studies was assessed with the I 2 measure (Higgins, Thompson, Deeks, & Altman, 2003 
| RE SULTS
The electronic database search resulted in 2,758 publications Tables 1-4 ). Sixty-two reports had to be excluded (Table 5 ).
| Study characteristics
Of the 18 clinical studies that were included in the analysis (Tables 1-3) , only 3 were prospective randomized clinical trials (RCT) that compared titanium (n = 71) and zirconia (n = 89, Payer et al., 2015) ) or immediately (n = 20) and conventionally (n = 20) loaded zirconia implants (Cannizzaro, Torchio, Felice, Leone, & Esposito, 2010) . Fifteen publications reported observational studies. Of those, 11 were prospectively and 4 retrospectively designed (Table 1) .
Most of the studies (n = 14) investigated 1-piece zirconia implants. Only 4 publications examined 2-piece zirconia implant systems (Table 1) . When 2-piece implants were investigated, abutments as well as prosthetics were cement-retained (Table 2) . With regard to zirconia implant diameter, the values ranged from 3.25 to 5.5 mm.
Implant placement was performed immediately after tooth extraction (type 1), after soft tissue (type 2) or osseous healing (types 3 and 4, Table 2 ). In addition, immediate (2 studies) and conventional loading (16 studies) were applied (Table 2) . Interestingly, 4 studies allowed early loading only for implants placed in the mandible, whereas conventional loading was applied for the maxilla (Jung et al., 2016; Spies, Balmer, Patzelt, Vach, & Kohal, 2015; Kohal, Knauf, Larsson, Sahlin, & Butz, 2012; Kohal, Patzelt, Butz, & Sahlin, 2013) .
The reported time periods between implant placement and installation of the final prosthetic reconstructions ranged between 6 and 30 weeks. Moreover, 14 studies allowed simultaneous bone regeneration during implant placement (Table 2) . With regard to prosthetic reconstructions, the investigated implants were exclusively restored with SCs (10 studies, 452 implants), with SCs or FDPs (5 studies, 386 implants), exclusively with RHDs (1 study, 73 implants) or FDPs (1 study, 56 implants) and with SCs, FDPs, or RHDs (1 study, 161 implants, Table 2 ). Unfortunately, not every study provided detailed information regarding the implant diameter and distribution, type of implant placement and prosthetic reconstructions. Specific information in terms of the implant design was available for 17 studies investigating 890 1-piece and 117 2-piece zirconia implants (Table 1 ). In addition, 1 study investigated 121 1-and 2-piece zirconia implants.
However, the authors did not provide detailed information regarding the exact implant distribution (Brull, van Winkelhoff, & Cune, 2014) .
The evaluated zirconia implants were placed in a university setting (718 implants), in a private practice (334 implants) or in a multicenter setting consisting of university and private practice (76 implants, Table 1 ).
In 18 studies, 11 different zirconia implant types from 10 companies were evaluated. However, only 9 publications provided results for 5 types of CA zirconia implant surfaces: Zircon Vision: ZV 3, Straumann: PURE Ceramic Implant, Vita Zahnfabrik: Vitaclinical ceramic.implant, Bredent: Whitesky, Metoxit AG: Ziraldent (Table 1) .
| Implant survival
Considering all included studies, data from 1,128 zirconia implants and 741 patients were included in the present review with regard to implant survival. A total of 21 patients (2.8%) and 55 zirconia implants (4.9%) were reported as dropouts (Table 3) .
Overall, 44 implants were reported as early failures (3.9%), 19
implants as late failures (1.7%) and 22 implants as fractures (2.0%). Thus, 7.5% of all investigated implants failed. Six studies provided detailed information regarding reasons for early and late implant failures. Interestingly, in the latter studies, implant mobility without any clinical signs of infection was reported as a reason for early and late failures (Brull et al., 2014; Cannizzaro et al., 2010; Cionca, Muller, & Mombelli, 2015; Kohal et al., 2012 Kohal et al., , 2013 Roehling et al., 2016) .
| NCA zirconia implants
Nine studies reporting data on 618 implants and 343 patients were included ( Table 1 ). The survival rates ranged between 71.2% and 100% for an overall mean observation period of 6 years (range 12-71 months, However, the authors used a novel, unestablished surgical protocol combining alveolar and palatal implants in the maxilla. Thus, 16 months after implant placement, survival rates 82.1% for titanium and of 71.2% for zirconia were observed. Additionally, when comparing different loading protocols for 1-piece zirconia implants restored with cement-retained SCs, decreased survival rates were reported for immediately (85%) compared to conventionally loaded (90%) implants at 12 months after placement (Cannizzaro et al., 2010) .
Considering NCA zirconia implants, the meta-analysis estimated a 1-year zirconia implant survival rate of 91.2% (CI 85.7-96.6). For the included studies, a high degree of heterogeneity was evaluated (I 2 = 96.4%, p < 0.01, Figure 2 ).
| CA zirconia implants
A total of 510 zirconia implants and 398 patients were investigated in 9 studies (Table 1) . The reported survival rates ranged from 93.3%
to 100% for mean follow-up periods between 12 and 61.20 months (5.10 years, Table 3 ). Overall, 12 implants (2.4%) failed (early failures:
8 implants (1.6%), late failures: 3 implants (0.6%), fractures: 1 implant (0.2%)). postextraction group. Thus, after a mean follow-up period of more than 5 years after placement (mean 61.2 months), survival rates of 93.3% and 100% were evaluated for type 1 and type 4 implant placement, respectively (Grassi et al., 2015) . In contrast, equivalent survival rates (100%) were reported 15 months after implant placement for 1-piece zirconia implants restored with cement-retained SCs when type 1 or type 3 and 4 implant placements were applied (Kniha et al., 2017) .
When considering CA zirconia implants, the meta-analysis estimated a 1-year survival rate of 98.3% (CI 97.0-99.6). For the evaluated studies, a moderate degree of heterogeneity was estimated (I 2 = 52.7%, p = 0.02, Figure 2 ). CA zirconia implants showed statistically significantly increased implant survival rates compared with NCA zirconia implants (p = 0.028).
The meta-regression for CA zirconia implants showed that type 1 implant placement, immediate temporization, immediate loading and simultaneous bone augmentation procedures did not have any significant effect on the reported 1-year survival rates (p > 0.05, Figure 3 ).
Moreover, studies that evaluated SCs and FDPs showed similar survival rates compared to studies exclusively investigating SCs (p > 0.05, Figure 4) . Interestingly, the meta-regression estimated higher survival rates for YTZP compared with ATZ and for 1-piece compared with 2-piece zirconia implants. However, these differences were not statistically significant (p > 0.05, Figure 3 ).
For a reduced number of studies reporting data for 192 implants and 159 patients, a 2-year meta-analysis could be performed (Becker et al., 2017; Grassi et al., 2015; Payer et al., 2013; Spies, Balmer, et al., 2015) . A mean 2-year survival rate of 97.2% (CI 94.7-99.7) and a moderate degree of heterogeneity (I 2 = 58.0%, p = 0.036) was estimated (Figure 4 ). In addition, the meta-regression showed that the confounding factors did not have any significant effect on the survival rates (p > 0.05, Figure 5 ).
| Peri-implant marginal bone loss
Fourteen studies investigating 839 zirconia implants and 558 patients reported detailed marginal bone loss evaluations between implant placement and follow-ups (Table 3) . Two studies had to be excluded from the 1-year MBL analysis as only panoramic radiographs were evaluated (Roehling et al., 2016) or detailed MBL values were only provided after 2 years of investigation (Mellinghoff, Cacaci, & Detsch, 2015) . Thus, 12 studies evaluating periapical radiographs could be included in the 1-year meta-analysis (Figure 6 ).
| NCA zirconia implants
Data from 251 implants and 273 patients were available. The metaanalysis evaluation estimated a mean 1-year marginal bone loss
TA B L E 5 Excluded studies

Reason for exclusion Number Studies
Studies investigating alumina dental implants 2 Pigot, Dubruille, Dubruille, Mercier, and Cohen (1997), Stuge and Ellingsen (1991) Review articles 19 Andreiotelli, Wenz, et al. (2009 ), Apratim et al. (2015 , Buser, Sennerby, and De Bruyn (2017) , Chen, Moussi, Drury, and Wataha (2016) , Depprich et al. (2014) , Elnayef et al. (2017) , Hashim et al. (2016) , Hisbergues, Vendeville, and Vendeville (2009 ), Hobkirk and Wiskott (2009 ), Kohal, Att, Bächle, Butz, and Author (2008 , Kumar, Jain, Jayesh, Parthasaradhi, and Venkatakrishnan (2015) , Ozkurt and Kazazoglu (2011), Özkurt and Kazazoĝlu (2010) , Pieralli et al. (2017) , Prithviraj, Deeksha, Regish, and Anoop (2012) , Regish, Sharma, and Prithviraj (2013) , Van Dooren et al. (2012) , Vohra et al. (2015) , Wenz, Bartsch, Wolfart, and Kern (2008) Case reports/case series of less than 10 patients 12 Arnetzl et al. (2010) , Aydin, Yilmaz, and Ata (2010) , Aydin, Yilmaz, and Bankoglu (2013) , Bankoglu Gungor, Aydin, Yilmaz, and Gul (2014) , Borgonovo, Boninsegna, Dolci, Ghirlanda, and Censi (2010b) , Kohal and Klaus (2004) , Mehra and Vahidi (2014) , Oliva (2008a,b, 2010b) , ParmigianiIzquierdo, Cabana-Munoz, Merino, and Sanchez-Perez (2017), Sierraalta and Razzoog (2009) Clinical studies investigating root shaped, individually designed zirconia implants 6 Nair, Prithviraj, Regish, and Prithvi (2013) , Patankar, Kshirsagar, Patankar, and Pawar (2016) , Pirker and Kocher (2008 ), Pirker, Wiedemann, Lidauer, and Kocher (2011 Clinical studies: Multiple publications on the same patient population 14 Borgonovo et al. (2011), Borgonovo, Arnaboldi, Censi, Dolci, and Santoro (2010) , Borgonovo et al. (2015) , Borgonovo, Corrocher, et al. (2013) Borgonovo, Fabbri, Vavassori, Censi, and Maiorana (2012) , , Gahlert, Burtscher, et al. (2012) ; Gahlert et al. (2013) , Kniha et al. (2016) , Oliva, Oliva, and Oliva (2007) , , Osman, Payne, Duncan, and Ma (2013) , Siddiqi, Kieser, De Silva, Thomson, and Duncan (2015) , Spies, Sperlich, Fleiner, Stampf, and Kohal (2016b) Clinical studies only investigating prosthetic outcomes and not zirconia implant survival 4 Spies, Kohal, Balmer, Vach, and Jung (2017) , Spies, Patzelt, Vach, and Kohal (2016) , Spies, Stampf, and Kohal (2015) , Spies, Witkowski, Butz, Vach, and Kohal (2016) Data not clear for evaluation 4 Blaschke and Volz (2006), Lambrich and Iglhaut (2008) , Mellinghoff (2006) , Oliva, Oliva, and Oliva (2010a) Publications based on charts, questionnaires or interviews 1 Jank and Hochgatterer (2016) of 1.0 mm (CI 0.6-1.3). A high degree of heterogeneity was noted across the studies (I 2 = 93.2%, p < 0.01, Figure 6 ).
| CA zirconia implants
Overall, data from 376 implants and 285 patients were available. The evaluated mean 1-year marginal bone loss was 0.7 mm (CI 0.4-1.0).
Again, a high degree of heterogeneity was found between the studies (I 2 = 95.9%, p < 0.01, Figure 6 ). The difference between NCA and CA zirconia implants was statistically not significant (p = 0.28).
The meta-regression for CA zirconia implants revealed that the type of implant placement, simultaneous bone augmentation procedures during implant placement, zirconia implant material and implant design did not have any significant effect on MBL (p > 0.05, Figure 5 ).
Interestingly, temporization directly after implant placement and immediate implant loading were associated with increased MBL. However, these differences were not statistically significant (p > 0.05, Figure 7 ).
| Technical complications
Only 5 F I G U R E 3 Effects of single factors on 1-year survival of CA zirconia implants. Illustrated are the estimated coefficients, including 95% confidence intervals. Coefficients >0 imply a positive effect on survival and coefficients <0 a negative effect on survival. All single 95% confidence intervals crossing the zero line imply no significant effect on implant survival types of implant generations together (NCA and CA zirconia implants), an overall complication rate of 3.4% was evaluated.
| NCA zirconia implants
When technical complications were observed for 1-piece zirconia implants restored with cement-retained SCs, the authors reported chipping of the veneering ceramic, fractures of the cemented crowns (4 SCs, 2.9%) or decementation (1 SC, 0.7% (Cannizzaro et al., 2010; Mellinghoff et al., 2015) ). Moreover, when 2-piece zirconia implants were evaluated, 2 ATZ abutment fractures (1.4%) were observed during the functional loading period after cementation of the abutments and SCs. However, abutment fractures were not associated with zirconia implant fractures (Cionca et al., 2015) . The overall technical complication rate for NCA zirconia implants was 5%.
| CA zirconia implants
Technical complications (1 SC chipping, fracture of the ceramic crown, 0.8%) were only reported for 2-piece zirconia implants restored with cement-retained SCs. In the same study, 1 fiberglass abutment fracture (0.8%) was observed during the loading period after cementation of the abutment and SC. Again, abutment fractures were not associated with implant fractures (Becker et al., 2017) . Thus, an overall technical complication rate of 1.6% was evaluated for CA zirconia implants.
| Zirconia implant fractures
Three studies reported a total of 22 zirconia implant fractures (1.95%) in 16 patients (Tables 1 and 3) .
| NCA zirconia implants
Twenty-one of 618 implants fractured (3.40%). Most of the fractures were observed in 1 study. In detail, Roehling et al. (2016) 
| CA zirconia implants
One of 510 zirconia implants fractured (0.20%). However, no information with regard to implant design, diameter, location and time point of implant fracture was reported (Brull et al., 2014) .
| Biological complications
Overall, clinical and radiographic data from 1117 implants (689 × NCA zirconia implants, 428 × CA zirconia implants) were considered (Table 4) .
| NCA zirconia implants
One study observed hypertrophic gingiva at 4 months after implant placement approximately 1 of 40 1-piece zirconia implants restored with cement-retained SCs (Cannizzaro et al., 2010) . In addition, 2 studies investigating 1-piece zirconia implants evaluated marginal bone loss of more than 2 mm within the first year after implant placement for 41% and 39% of the investigated implants restored with cement-retained SCs and FDPs, respectively (Kohal et al., 2012 (Kohal et al., , 2013 . Overall, the incidence of biological complications was 7.3%.
F I G U R E 6
Forest plot of 1-year marginal bone loss of NCA and CA zirconia implants. No significant differences between NCA and CA zirconia implants F I G U R E 7 Effects of single factors on 1-year MBL of CA zirconia implants. Illustrated are the estimated coefficients, including 95% confidence intervals. Coefficients >0 imply an increase in MBL and coefficients <0 a decrease in MBL. All single 95% confidence intervals crossing the zero line imply no significant effect on MBL
| CA zirconia implants
One study reported "initial peri-implantitis" between 12 and 24 months after implant placement approximately 18 (37.5%) of 48 investigated 2-piece zirconia implants restored with cementretained SCs. However, MBL analyses were not provided (Becker et al., 2017) . Thus, an overall incidence of 4.2% was evaluated for biological complications.
| Aesthetic outcomes
Soft tissue outcomes were evaluated for 1-as well as for 2-piece zirconia implants restored with cement-retained SCs.
| NCA zirconia implants
A prospective RCT investigated 2-piece implants and directly compared titanium implants (restored with titanium abutments and ceramic crowns) to zirconia implants (restored with zirconia abutments and ceramic crowns). At baseline, after 6, 12, 18 and 24 months after crown cementation, PES scores of 2.4, 6.5, 9.0, 8.1 and 10.8, respectively, were reported for titanium. In contrast, zirconia implants showed significantly increased PES values of 6.9, 8.0, 10.3, 11.0 and 11.2 at corresponding time points (Payer et al., 2015) . Another study observed that 69.8% of the placed 1-piece zirconia implants showed papilla scores of 2 and 3 according to Jemt after a mean follow-up period of 14.25 months (Hollander et al., 2016) .
| CA zirconia implants
A prospective observational study investigated twenty 1-piece zirconia implants. PES scores of 8.1, 9.0 and 10.0 were reported at crown cementation, 12 and 24 months after implant placement.
However, this increase was not statistically significant (Payer et al., 2013) . When using the papilla index according to Jemt, a significant increase in papilla growth within the course of the investigation has been reported for 1-piece zirconia implants. In detail, only 17%
of the papillae revealed indices of 2 and 3 at crown cementation, whereas 3 years after implant placement, this distribution significantly increased up to 56% (Spies, Balmer, et al., 2015) .
| D ISCUSS I ON
Implant survival was evaluated as one of the primary outcomes.
Regarding NCA zirconia implants, the reported survival rates widely ranged between 71.2% and 100%, whereas the estimated mean 1-year survival rate was 91.15% (Table 4 , Figure 2 ). Studies evaluating low overall survival rates of less than 80% observed high early implant failure and fracture rates Roehling et al., 2016) . CA zirconia implants showed less variation with regard to the reported survival rates (93.3%-100%) and a statistically significantly increased estimated mean 1-year survival rate (98.3%) compared with NCA zirconia implants (p = 0.028).
In detail, more early and late failures as well as a higher implant 0.7-1.17 μm, Table 2 ). Consequently, the significantly improved survival rates might not just be attributed to increased quantitative surface roughness characteristics, but mainly to the 17 times higher fracture incidence for NCA zirconia implants compared with CA zirconia implants. However, it must be noticed that a comparison of single surface roughness parameters reported in different studies is not reasonable as standards and techniques for the used surface metrologies vary, and a successful osseointegration is not exclusively linked to one particular surface roughness feature (Jarmar et al., 2008; Wennerberg & Albrektsson, 2010) .
In addition to quantitative surface roughness, the morphological micro-textures and the surface treatment procedures are of high relevance for the osseous integration of zirconia implants, as experimental studies have reported that sandblasted and acid-etched zirconia implants with a surface roughness of 0.6 μm show similar bone-to-implant contact and removal torque out values compared with sandblasted and acid-etched titanium implants with a surface roughness of 1.2 μm Gahlert et al., 2009; Gahlert, Burtscher, et al., 2012; Gahlert, Roehling, et al., 2012) .
When detailed information regarding early and late implant failures was provided, the authors reported that the suddenly noted implant mobility was not accompanied by any clinical signs of infection for cement-retained SCs on 2-piece implants (Cionca et al., 2015) and for cement-retained SCs and FDPs on 1-piece implants (Kohal et al., 2012 (Kohal et al., , 2013 Roehling et al., 2016) . Cionca et al., 2015 described these observations as "aseptic loosening", a term that was initially used in orthopedic total hip replacement surgery. The authors of the latter studies concluded that not bacterial infections but rather disintegration or premature loading may have caused the implant failures (Cionca et al., 2015; Kohal et al., 2012 Kohal et al., , 2013 Roehling et al., 2016) . These findings are in contrast to results obtained for titanium implants showing that the main reasons for early implant failure were peri-implant inflammation, followed by failure of osseointegration (Han, Kim, & Han, 2014) . The presently evaluated mean 1-and 2-year survival rates of 98.30% and 97.2%, respectively, for CA zirconia implants are comparable to data reported in systematic reviews on titanium implants, describing mean 1-year survival rates ranging from 96.8% to 99.5% (Benic, Mir-Mari, & Hammerle, 2014; Chambrone, Shibli, Mercurio, Cardoso, & Preshaw, 2015; Karl & Albrektsson, 2017) . Previously, meta-analyses investigating zirconia implants reported 1-year survival rates of 92% (Hashim et al., 2016) and 95.6% (Pieralli et al., 2017) , which are inferior compared with the presently evaluated survival rates for CA zirconia implants.
However, both latter reviews evaluated overall survival rates that combined NCA and CA zirconia implants.
Based on the clinical relevance and significant impact on implant survival, the influence of confounding factors on primary outcomes using meta-regressions was evaluated only for CA zirconia implants.
Immediate and conventional loading as well as early and late placement of zirconia implants showed reliable clinical outcomes within follow-up periods up to 2 years. However, immediate implant loading and type 1 implant placement tended to be associated with a nonsignificant decrease in implant survival (Figures 3 and 5) . In addition to that, increased survival rates were calculated for 1-compared with 2-piece and for YTZP compared with ATZ zirconia implants.
Again, the effects on survival rates were not statistically significant (Figures 3 and 5) . It should be noted that these results also might have been influenced by the inclusion in the present review of only 2 studies investigating 2-piece zirconia implant systems and only 1 study evaluating ATZ implants ( Table 1) .
As an additional primary outcome, MBL was analyzed. The metaanalysis estimated a decreased mean 1-year MBL for CA (0.67 mm) compared with NCA zirconia implants (0.95 mm), but this difference was not statistically significant. Interestingly, all 2-piece zirconia implant systems that were included in the present review had a tissue level design. In this context, it must be noted that MBL is not only dependent on surface roughness or implant design (Hermann, Buser, Schenk, & Cochran, 2000; Valderrama et al., 2011) but also on surgical trauma during implant placement (Cochran et al., 1996) or the position of the rough/smooth border of 1-piece implants; in contrast, a subcrestal implant shoulder position leads to increased crestal bone loss (Hartman & Cochran, 2004; Hermann, Cochran, Nummikoski, & Buser, 1997; Hermann et al., 2011) .
The mean 1-year MBL for CA zirconia implants (0.67 mm) is in agreement with previously published pooled data on NCA and CA zirconia implants after 1 year of investigation (0.79 mm, CI 0.73-0.86, (Pieralli et al., 2017) ) and comparable to titanium implants after follow-up periods from 1 to 5 years (range 0.41-0.89 mm, (Karl & Albrektsson, 2017) ). The meta-regression analysis for CA zirconia implants showed that none of the confounding factors had any significant effect on MBL ( Figure 5 ). Based on the observation that only 1 publication provided pooled MBL values for 1-and 2-piece zirconia implants (Brull et al., 2014) , implant design (1-piece compared with 2-piece macro design)
could not be considered in the meta-regression evaluation for MBL.
In the present review, technical complications and implant fractures were considered as separate factors as only a few publications reported technical complications (Becker et al., 2017; Cannizzaro et al., 2010; Cionca et al., 2015; Jung et al., 2016; Mellinghoff et al., 2015) , whereas information with regard to implant fractures was available for all included studies (Tables 3 and 4 ). The fracture incidence of NCA zirconia implants was clearly associated with a decreasing implant diameter (Roehling et al., 2016) . Experimental investigations have shown that zirconia implants have the ability to withstand the forces of the oral cavity Silva et al., 2009 ). However, uncontrolled surface treatment procedures like conventional sandblasting or uncontrolled machining or grinding processes can lead to surface micro-cracks and might reduce the fracture strength and lead to implant fractures in NCA 1-piece zirconia dental implants (Gahlert, Burtscher, et al., 2012; . Thus, manufacturing as well as uncontrolled grinding processes or a reduced implant diameter of NCA zirconia implants might have promoted the implant fractures reported in the present review. The presently evaluated fracture rate of 0.2% for CA zirconia implants is comparable to data reported in a systematic review on titanium implants, describing a mean titanium implant fracture rate of 0.2% after 5 years (Jung, Zembic, Pjetursson, Zwahlen, & Thoma, 2012) .
With respect to biological complications, 2 studies investigating 1-piece NCA zirconia implants evaluated marginal bone loss of more than 2 mm within the first year after implant placement (Table 4) .
Interestingly, the authors of the latter studies reported that the increased MBL was not caused by inflammatory reactions to plaque or bacteria, but possibly were caused by the implant design or cement remnants in the peri-implant soft tissues (Kohal et al., 2012 (Kohal et al., , 2013 .
Regarding CA zirconia implants, peri-implant infections were reported in 1 study and described as "initial peri-implantitis", whereas longitudinal MBL data were not provided. Interestingly, the authors observed only "minor crestal bone levels not exceeding the upper 25% of the implant length" and only "moderate" probing depth values for the respective implants (Becker et al., 2017) . Thus, a more pronounced physiological marginal bone level remodeling influenced by the implant design or surgical trauma during implant placement and not bacterial infection/peri-implantitis might rather be considered as a reason for the reported findings. The presently evaluated biological complication incidence of 4.2% for CA zirconia implants is comparable to data reported in systematic reviews on titanium implants for observation periods from 1 to 5 years (range 5.2%-7.1%, (Jung et al., 2012; Karl & Albrektsson, 2017; Zembic, Kim, Zwahlen, & Kelly, 2014) ).
As a limiting factor of the present review, it should be noted that a wide range of quality of the reported clinical data was noted among the included studies. Thus, not every clinical relevant parameter could be extrapolated for analysis in the present review (e. g., implant diameter, implant location, type of implant placement, bone augmentation procedures, type of prosthetic reconstruction, prosthetic outcomes). In addition, the reported mean observation periods ranged from 12.00 to 71.28 months (5.94 years). Due to the wide variation regarding the follow-up periods, only 1-year meta-analyses and meta-regressions could be evaluated with regard to the primary outcomes when all included studies were considered. Thus, for the evaluation of the 2-years meta-analyses and meta-regressions, studies with observation periods of only 12 months had to be excluded.
Based on the available clinical data, a statement concerning the clinical performance of zirconia compared with titanium implants is not possible as only 2 RCTs directly compared NCA zirconia to titanium implants Payer et al., 2015) . Moreover, the results of the present review showed that the available clinical data for zirconia implants can be confusing as different generations of zirconia implants have been scientifically investigated since the early 2000s. The market availability of zirconia implant generations should be considered when interpreting results from evidence-based investigations, a feature that becomes even more relevant since clinical studies and even meta-analysis published between 2016 and 2017 report outcomes for NCA zirconia implants (Hashim et al., 2016; Hollander et al., 2016; Pieralli et al., 2017; Roehling et al., 2016) . 
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